Medscape News

Link Description
EU Clears Brodalumab (Kyntheum) for Plaque Psoriasis Brodalumab is for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. <br /> <i>International Approvals</i
&#39;This Is My Reality&#39; What's it like to live with a chronic disease, day in and day out? <br /> <i>Medscape Diabetes & Endocrinology</i
Urologist Loses Lawsuit for Removing Wrong Testicle Jury rejects doctor's anatomically questionable defense; no malpractice crisis in one southern state; in another state, those who've been harmed by medical error may find it
Ketamine: Another Option for Managing Acute Pain? Dr Sumit Patel reviews a study that compared pain control in patients who received either placebo + opioids or ketamine + opioids. <br /> <i>Medscape Emergency Medicine</i
Reducing CV Risk in Diabetes: &#39;When&#39; and &#39;How&#39; Matter Reducing cardiovascular risk with glycemic control may depend on when and how it is achieved. <br /> <i>Medscape Diabetes & Endocrinology</i
FDA Clears Pan-Genotypic Vosevi for Chronic Hepatitis C Vosevi, a combo of two previously approved drugs and newly approved voxilaprevir, is the first treatment approved for patients who have been previously treated with the direct-
Bacteremia and the Pneumococcal Vaccines How has the introduction of the pneumococcal conjugate vaccines influenced bacteremia rates in young children? <br /> <i>Medscape Pediatrics</i
What to Know About the NAMS Updated Position on Hormone Therapy Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. <br /> <i>Medscape Ob/Gyn</i
Probiotics and Weight Loss Not surprisingly, there has been a lot of interest in manipulating the gut microbiota to facilitate weight loss. How might probiotics play a role? <br /> <i>Medscape Pharmacists</
What to Do When a Child Has a Toxic Exposure A free resource helps clinicians identify and manage toxic exposures in children and improve health outcomes. <br /> <i>CDC Expert Commentary</i
FDA OKs Biologic Guselkumab (Tremfya) for Plaque Psoriasis Guselkumab is the first and only approved biologic agent that selectively blocks interleukin-23, a key player in plaque psoriasis. <br /> <i>FDA Approvals</i
Can an OTC Hearing Device Substitute for a Hearing Aid? Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care. <br /> <i>Medscape Internal Medicine</i